Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-6-18
|
pubmed:abstractText |
The clinical expression of rheumatoid arthritis (RA) varies considerably among individual patients. Genetic variations in human leucocyte antigen (HLA) may influence clinical expression. We re-examined the association of HLA-DR with susceptibility to and clinical expression of RA using genomic tissue typing, since most studies were based on (less reliable) serological techniques. Seventy-eight patients with recent-onset RA, all participating in a clinical trial on therapeutic strategies, were HLA-DR typed by means of low-resolution genomic typing. Cumulative disease activity within the first 3 yr of disease was measured. Of the RA patients, 54% expressed DR4 (DR4+) vs 26% of healthy controls. Rheumatoid factor (RF)-positive patients had a higher cumulative disease activity than RF-negative patients. Patients who were either DR1+ or DR4+ had a higher cumulative disease activity than those who expressed neither DR1 nor DR4. This association was less obvious after correction for RF status. The association of DR52+ (DR3, 5, 6) and a lower cumulative disease activity could also not be demonstrated after correction for RF status. Among RF-negative patients, DR51+ (or DR2+) was associated with a higher cumulative disease activity. Other HLA-DR types (including DR1 and DR4 separately) were not associated with the severity of RA. DR4 was associated with susceptibility to RA in our patients; HLA-DR low-resolution genomic tissue typing did not yield additional information to RF status for the clinical identification of individual patients with a poor prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0263-7103
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9619892-Adult,
pubmed-meshheading:9619892-Age of Onset,
pubmed-meshheading:9619892-Aged,
pubmed-meshheading:9619892-Arthritis, Rheumatoid,
pubmed-meshheading:9619892-Female,
pubmed-meshheading:9619892-Genome, Human,
pubmed-meshheading:9619892-HLA-DR Antigens,
pubmed-meshheading:9619892-Histocompatibility Testing,
pubmed-meshheading:9619892-Humans,
pubmed-meshheading:9619892-Longitudinal Studies,
pubmed-meshheading:9619892-Male,
pubmed-meshheading:9619892-Middle Aged,
pubmed-meshheading:9619892-Predictive Value of Tests,
pubmed-meshheading:9619892-Rheumatoid Factor
|
pubmed:year |
1998
|
pubmed:articleTitle |
Association of HLA-DR with susceptibility to and clinical expression of rheumatoid arthritis: re-evaluation by means of genomic tissue typing.
|
pubmed:affiliation |
Rheumatic Research Foundation Utrecht, Department of Rheumatology and Clinical Immunology, University Hospital Utrecht, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|